Strata Skin Sciences, Inc.
SSKN
$1.79
-$0.03-1.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.80% | 19.48% | 6.87% | -30.39% | -16.48% |
| Total Depreciation and Amortization | -6.06% | -8.29% | -10.08% | -10.60% | -4.42% |
| Total Amortization of Deferred Charges | 22.83% | 20.00% | 5.71% | -10.46% | -22.56% |
| Total Other Non-Cash Items | 24.65% | -9.06% | -4.77% | 43.99% | 43.02% |
| Change in Net Operating Assets | 93.58% | -78.29% | 1,097.10% | 162.90% | -0.51% |
| Cash from Operations | -142.46% | 187.35% | 136.22% | 150.03% | -123.90% |
| Capital Expenditure | 72.86% | 71.91% | 67.40% | 43.00% | 54.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 72.86% | 71.91% | 67.40% | 43.00% | 54.66% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 87.05% | 97.18% | 77.20% |
| Cash from Financing | 1,692.62% | -71.61% | -71.94% | -69.74% | -101.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.22% | -46.54% | -63.95% | 80.29% | -1,096.66% |